370 related articles for article (PubMed ID: 9973012)
21. Direct-current cardioversion of atrial tachyarrhythmias under oral flecainide therapy.
Leclercq JF; Bizot J; Attuel P; Coumel P
Am J Cardiol; 1997 Sep; 80(5):645-8. PubMed ID: 9295002
[TBL] [Abstract][Full Text] [Related]
22. Internal cardioversion of chronic atrial fibrillation in patients.
Neri R; Palermo P; Cesario AS; Baragli D; Amici E; Gambelli G
Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2237-42. PubMed ID: 9309749
[TBL] [Abstract][Full Text] [Related]
23. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
Naegeli B; Straumann E; Bertel O
Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation.
Boriani G; Biffi M; Bronzetti G; Ayers GM; Zannoli R; Branzi A; Capucci A; Magnani B
Am J Cardiol; 1998 Jan; 81(2):241-4. PubMed ID: 9591914
[TBL] [Abstract][Full Text] [Related]
25. [Idiopathic atrial fibrillation of recent onset and atrial stunning: the echocardiographic evidence after pharmacological cardioversion].
Ciolli A; De Sisti A; Montenero AS; Sanna T; Lo Sardo G; Palamara A
Cardiologia; 1998 Oct; 43(10):1077-82. PubMed ID: 9922572
[TBL] [Abstract][Full Text] [Related]
26. Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation.
Pohjantähti-Maaroos H; Hyppölä H; Lekkala M; Sinisalo E; Heikkola A; Hartikainen J
Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):114-120. PubMed ID: 28849946
[TBL] [Abstract][Full Text] [Related]
27. Internal cardioversion of atrial fibrillation in sheep.
Cooper RA; Alferness CA; Smith WM; Ideker RE
Circulation; 1993 May; 87(5):1673-86. PubMed ID: 8491023
[TBL] [Abstract][Full Text] [Related]
28. Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of the electrophysiological effects by biatrial basket electrodes.
Lai LP; Lin JL; Lien WP; Tseng YZ; Huang SK
J Am Coll Cardiol; 2000 May; 35(6):1434-41. PubMed ID: 10807444
[TBL] [Abstract][Full Text] [Related]
29. Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial.
Kirchhof P; Andresen D; Bosch R; Borggrefe M; Meinertz T; Parade U; Ravens U; Samol A; Steinbeck G; Treszl A; Wegscheider K; Breithardt G
Lancet; 2012 Jul; 380(9838):238-46. PubMed ID: 22713626
[TBL] [Abstract][Full Text] [Related]
30. Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results.
Lévy S; Ricard P; Gueunoun M; Yapo F; Trigano J; Mansouri C; Paganelli F
Circulation; 1997 Jul; 96(1):253-9. PubMed ID: 9236442
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a protocol to select patients of all ages for cardioversion from atrial fibrillation.
Lawson-Matthew PJ; Ionescu A; McHugh P; Channer KS
Age Ageing; 1997 Jul; 26(4):247-52. PubMed ID: 9271286
[TBL] [Abstract][Full Text] [Related]
32. Treatment of recent onset atrial fibrillation with intravenous sotalol and/or flecainide.
Peters FP; Braat SH; Heymeriks J; Wellens HJ
Neth J Med; 1998 Sep; 53(3):93-6. PubMed ID: 9803139
[TBL] [Abstract][Full Text] [Related]
33. Transvenous atrial cardioversion threshold in patients with implantable cardioverter defibrillator: influence of active pectoral can.
Heisel A; Jung J; Nikoloudakis N; Fries R; Schäfers HJ; Schieffer H
Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):253-7. PubMed ID: 9990641
[TBL] [Abstract][Full Text] [Related]
34. High energy transcatheter cardioversion of chronic atrial fibrillation.
Levy S; Lacombe P; Cointe R; Bru P
J Am Coll Cardiol; 1988 Aug; 12(2):514-8. PubMed ID: 3392346
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of internal cardioversion for chronic atrial fibrillation in patients with and without left ventricular dysfunction.
Boriani G; Biffi M; Camanini C; Corazza I; Martignani C; Valzania C; Gallina M; Grigioni F; Zannoli R; Rapezzi C; Branzi A
Int J Cardiol; 2004 May; 95(1):43-7. PubMed ID: 15159037
[TBL] [Abstract][Full Text] [Related]
36. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements.
Botto GL; Politi A; Bonini W; Broffoni T; Bonatti R
Heart; 1999 Dec; 82(6):726-30. PubMed ID: 10573502
[TBL] [Abstract][Full Text] [Related]
37. Active compression versus standard anterior-posterior defibrillation for external cardioversion of atrial fibrillation: A prospective randomized study.
Squara F; Elbaum C; Garret G; Liprandi L; Scarlatti D; Bun SS; Mossaz B; Rocher M; Bateau J; Moceri P; Ferrari E
Heart Rhythm; 2021 Mar; 18(3):360-365. PubMed ID: 33181323
[TBL] [Abstract][Full Text] [Related]
38. [Impact of electrical shock waveform and paddle positions on efficacy of direct current cardioversion for atrial fibrillation].
Stanaitiene G; Babarskiene RM
Medicina (Kaunas); 2008; 44(9):665-72. PubMed ID: 18971603
[TBL] [Abstract][Full Text] [Related]
39. Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study.
Er F; Aslan O; Caglayan E; Gassanov N; Nia AM; Erdmann E; Rosenkranz S
Clin Res Cardiol; 2010 Jun; 99(6):369-73. PubMed ID: 20180126
[TBL] [Abstract][Full Text] [Related]
40. Safety of transvenous low energy cardioversion of atrial fibrillation in patients with a history of ventricular tachycardia: effects of rate and repolarization time on proarrhythmic risk.
Simons GR; Newby KH; Kearney MM; Brandon MJ; Natale A
Pacing Clin Electrophysiol; 1998 Feb; 21(2):430-7. PubMed ID: 9507545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
